iso4217:EUR iso4217:EUR xbrli:shares 222100WPYK3JKB5F4D19 2024-01-01 2024-12-31 222100WPYK3JKB5F4D19 2023-12-31 222100WPYK3JKB5F4D19 2024-12-31 222100WPYK3JKB5F4D19 2025-01-01 2025-12-31 222100WPYK3JKB5F4D19 2025-12-31 222100WPYK3JKB5F4D19 2023-12-31 ifrs-full:StatutoryReserveMember 222100WPYK3JKB5F4D19 2024-01-01 2024-12-31 ifrs-full:StatutoryReserveMember 222100WPYK3JKB5F4D19 2024-12-31 ifrs-full:StatutoryReserveMember 222100WPYK3JKB5F4D19 2023-12-31 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 222100WPYK3JKB5F4D19 2024-01-01 2024-12-31 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 222100WPYK3JKB5F4D19 2024-12-31 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 222100WPYK3JKB5F4D19 2023-12-31 ifrs-full:TreasurySharesMember 222100WPYK3JKB5F4D19 2024-01-01 2024-12-31 ifrs-full:TreasurySharesMember 222100WPYK3JKB5F4D19 2024-12-31 ifrs-full:TreasurySharesMember 222100WPYK3JKB5F4D19 2023-12-31 luxempartsa:CapitalAndSharePremiumMember 222100WPYK3JKB5F4D19 2024-01-01 2024-12-31 luxempartsa:CapitalAndSharePremiumMember 222100WPYK3JKB5F4D19 2024-12-31 luxempartsa:CapitalAndSharePremiumMember 222100WPYK3JKB5F4D19 2023-12-31 luxempartsa:OtherReservesIncludingRetainedEarningsButExcludingProfitLossForReportingPeriodMember 222100WPYK3JKB5F4D19 2024-01-01 2024-12-31 luxempartsa:OtherReservesIncludingRetainedEarningsButExcludingProfitLossForReportingPeriodMember 222100WPYK3JKB5F4D19 2024-12-31 luxempartsa:OtherReservesIncludingRetainedEarningsButExcludingProfitLossForReportingPeriodMember 222100WPYK3JKB5F4D19 2025-01-01 2025-12-31 ifrs-full:StatutoryReserveMember 222100WPYK3JKB5F4D19 2025-12-31 ifrs-full:StatutoryReserveMember 222100WPYK3JKB5F4D19 2025-01-01 2025-12-31 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 222100WPYK3JKB5F4D19 2025-12-31 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 222100WPYK3JKB5F4D19 2025-01-01 2025-12-31 ifrs-full:TreasurySharesMember 222100WPYK3JKB5F4D19 2025-12-31 ifrs-full:TreasurySharesMember 222100WPYK3JKB5F4D19 2025-01-01 2025-12-31 luxempartsa:CapitalAndSharePremiumMember 222100WPYK3JKB5F4D19 2025-12-31 luxempartsa:CapitalAndSharePremiumMember 222100WPYK3JKB5F4D19 2025-01-01 2025-12-31 luxempartsa:OtherReservesIncludingRetainedEarningsButExcludingProfitLossForReportingPeriodMember 222100WPYK3JKB5F4D19 2025-12-31 luxempartsa:OtherReservesIncludingRetainedEarningsButExcludingProfitLossForReportingPeriodMember
Not named
Annual Report 2025
Not named
Annual Report 2025
Not named
TABLE OF
CONTENTS
Luxempart at a glance
5
Message to our shareholders
6
Strategy
10
Focus on our activities
12
Focus on our activities
14
Direct Investments
18
Investment Funds
26
Management report
32
Activity & performance
34
Direct Investments
38
Investment Funds
40
Sustainability
42
Our team
46
APM and other information
50
Portfolio
56
Direct Investments
58
Investment Funds
82
Corporate Governance
84
Statement of corporate governance
86
Shares & Capital
87
General Meeting of Shareholders
89
Board of Directors
90
Specialised Committees
97
Group Executive Committee
100
Principles of Corporate Governance
104
Internal control and risk management
106
Remuneration report
110
Consolidated financial statements
116
Statutory annual accounts
160
Glossary
180
2ꢀ -ꢀ LUXEMPART ANNUAL REPORT 2025
Not named
LUXEMPART ANNUAL REPORT 2025ꢀ -ꢀ 3
Not named
4ꢀ -ꢀ LUXEMPART ANNUAL REPORT 2025
Not named
LUXEMPART
AT A GLANCE
LUXEMBOURGISH INVESTMENT COMPANY
€ 2.5bn NAV
AS AT 31/12/2025
STRONG TRACK RECORD
14.5% IRR
+10%
OVER THE PAST 30+ YEARS
STRONG TEAM
~
30
32%
INVESTMENT AND CORPORATE PROFESSIONALS
DIRECT INVESTMENTS
27 lines
40
IN EUROPE
STOCK LISTED, EVERGREEN
30+ years
OF EXISTENCE
STEADY DIVIDEND POLICY
PROPOSED DIVIDEND INCREASE
LARGEST ASSET
OF FOYER GROUP
INVESTMENT FUNDS
BEST-IN-CLASS FUND MANAGERS, EUROPE & US
LUXEMPART ANNUAL REPORT 2025ꢀ -ꢀ 5
Not named
MESSAGE TO OUR
SHAREHOLDERS
JOHN PENNING
MANAGING DIRECTOR
FRANÇOIS GILLET
CHAIRMAN
6ꢀ -ꢀ LUXEMPART ANNUAL REPORT 2025
Not named
Dear Shareholders,
2025 marked a year of renewed momentum for Luxempart.
While the macroeconomic environment remained uncer-
tain and geopolitical tensions continued to weigh on
sentiment, we observed improving market dynamics
and a gradual return of investment activity across our
core markets. Against this backdrop, Luxempart delivered
a good performance and continued to execute its long-
term investment strategy with discipline and conviction.
Our portfolio once again demonstrated the benefits of
diversification and active management. Across both Direct
Investments and Investment Funds, we saw encouraging
operational developments and attractive opportunities
for capital deployment.
GOOD PERFORMANCE IN 2025
In 2025, Luxempart delivered a solid performance with
a Net Asset Value return of 11.3%, reflecting the strength
of our core portfolio companies and the continued resil-
ience of our investment strategy. This performance was
achieved despite an environment that remained uneven
across sectors and geographies.
Direct Investments generated a +14.3% return, driven in
particular by the strong performance of our core holdings.
The insurance sector performed well during the year,
benefiting from a favorable interest rate environment,
and several of our key portfolio companies delivered
solid operational progress.
At the same time, our Investment Funds activity produced
a +9.9% return (+12.2% excluding FX effects). Our expo-
sure to lower mid-market buyout and secondaries funds
continued to demonstrate resilience and generate attrac-
tive results, reaffirming the quality of our fund manager
partnerships.
A DYNAMIC YEAR FOR INVESTMENTS
AND DIVESTMENTS
Investment activity accelerated during the year as market
conditions gradually improved. In total, Luxempart
deployed EUR 165m in 2025, with EUR 92m invested
in Direct Investments and EUR 73m deployed to
Investment Funds. Despite a difficult exit environment,
we were able to generate proceeds of EUR 222m, of
which EUR 81m distributions from our funds.
"Our performance in 2025
reflects both the strength
of our portfolio companies
and the discipline of our
two-pillar investment
strategy, which continues
to position Luxempart for
long-term value creation."
JOHN PENNING
Within Direct Investments, a highlight was the signing in
December 2025 of a EUR 78m investment in Valeara,
a leading ambulatory mental health care platform in
Germany. This transaction, which was closed in January
this year, further strengthens our exposure to the
healthcare sector and illustrates our ability to identify
attractive opportunities in our priority verticals.
Looking ahead, our objective remains to continue build-
ing a focused Direct Investments portfolio of about 15
meaningful holdings, with an average entry equity ticket
of EUR 40m to 75m with the option to increase our posi-
tions over time. This approach will allow us to further
concentrate our capital behind our strongest convictions
while maintaining our ambition of doubling the value
of our investments over a five-year horizon.
LUXEMPART ANNUAL REPORT 2025ꢀ -ꢀ 7
Not named
CONTINUING TO STRENGTHEN OUR
INVESTMENT PLATFORM
Luxempart's strategy remains firmly anchored around
its two complementary investment pillars.
Direct Investments represents 66% of NAV, consisting
of 27 portfolio companies. Within this segment, our 14
core investments account for the vast majority of value
creation, representing 59% of NAV and 90% of the Direct
Investments portfolio. In addition to these core holdings,
we nurture a portfolio of smaller co-investment posi-
tions alongside high-quality partners such as Armira,
Cobepa, Eurazeo, Ekkio and Seven2.
Our Investment Funds portfolio represents 25% of NAV,
with small and mid-cap buyout accounting for the major-
ity of exposure. Venture and growth strategies represent
a smaller portion of the portfolio (5% of NAV) and our
focus lies on further strengthening lower mid cap buyout
and growth buyout.
Besides our core investment in Foyer, across both pillars,
we remain focused on our four priority sectors — health-
care, software, industrials, and B2B services — where we
see strong structural growth and compelling long-term
opportunities.
STRENGTHENING ALIGNMENT
THROUGH AN EVOLVED
REMUNERATION FRAMEWORK
Over the past year, we conducted a comprehensive
review of the incentive framework for our teams to
ensure it remains fully aligned with Luxempart's strat-
egy and long-term objectives.
Starting in 2026, we will implement an updated remu-
neration policy designed to place greater emphasis on
our two-pillar investment model. The new framework
strengthens incentives within both Direct Investments
(excluding Foyer) and Investment Funds, encouraging
teams to further develop expertise and performance
within their respective activities.
"We are pleased that John
who is at the heart of the
execution of our strategy
will take over the leadership
of Foyer Finance, which is
our reference shareholder.
In that role he will
continue to support the
development of Luxempart
and be the guardian of the
entrepreneurial family
culture. For now, John
remains fully engaged
at Luxempart until his
successor is appointed."
FRANCOIS GILLET
On the Investment Funds side, 2025 was a particularly
active year. We took new commitments for EUR 138m,
adding nine new managers to our portfolio across the
United States and Europe. Our Investment Funds total
exposure (NAV plus outstanding commitments) has now
grown to EUR 949m further strengthening this impor-
tant pillar of our strategy. Our exposure to the US dollar
amounts to 6% of NAV but already represents slightly
more than a third of IF total exposure.
8ꢀ -ꢀ LUXEMPART ANNUAL REPORT 2025
Not named
A key element of this evolution is the introduction of
a reinforced long-term incentive component which will
include stock options. This mechanism aims to deepen
the alignment between our teams and our shareholders
by linking a portion of compensation directly to long-
term value creation.
By reinforcing this culture of ownership and long-term
commitment, we believe this new framework will fur-
ther strengthen Luxempart's entrepreneurial spirit and
support the continued execution of our strategy.
A STRONG FINANCIAL POSITION TO
SEIZE OPPORTUNITIES
Luxempart's balance sheet remains a key strength. At
year-end 2025, our liquidities amounted to EUR 212m,
representing 8.4% of NAV.
In addition, we have access to fully committed undrawn
credit facilities, bringing our total available financial
resources to more than EUR 400m. This financial flexi-
bility allows us to remain agile — both in honoring our
commitments to the funds and in pursuing new direct
investment opportunities as they arise.
GOVERNANCE EVOLUTION AND
LEADERSHIP CONTINUITY
In February 2026, we announced the initiation of a
succession process for our Managing Director, John
Penning, as part of a broader governance evolution
within the Group's shareholder structure.
This transition is taking place in a context of stability
and strategic continuity. Once a successor has been
appointed, John Penning will remain closely involved
with the Group as a member of Luxempart's Board of
Directors and will assume the leadership of a newly
created Executive Committee at Foyer Finance SA, the
reference shareholder of Luxempart.
This planned transition forms part of a broader suc-
cession trajectory within the family group and reflects
our commitment to maintaining strong governance and
long-term leadership continuity.
A CONTINUED FOCUS ON
SHAREHOLDER VALUE
We are pleased to announce that our Board of Directors
is proposing a dividend of EUR 2.56 per share, rep-
resenting a 10% increase compared to last year and
corresponding to a dividend yield of 4.1% based on the
year-end share price.
Our entrepreneurial spirit and long-term investment
mindset continue to guide our decisions. In a world
shaped by increasing geopolitical uncertainty, this dis-
ciplined and patient approach is more important than
ever. By partnering with ambitious management teams
and leading investment managers, we aim to continue
creating sustainable value for our shareholders over
the long term.
We extend our sincere gratitude to our Board of Directors
for their guidance and support. We also thank our teams
across Luxembourg, Munich, and Paris for their dedica-
tion and professionalism. Finally, to our shareholders,
we thank you for your continued trust.
We remain fully committed to building on Luxempart's
strong foundations and to capturing the opportunities
that lie ahead.
LUXEMPART ANNUAL REPORT 2025ꢀ -ꢀ 9
Not named
STRATEGY
Values
We are defined by our family roots, driven
by passion and guided by values that have
shaped our success:
∙ Positive alignment with our partners
∙ Resilience in challenges
∙ Honesty and respect for people
∙ Passion for the business
∙ Solution-oriented thinking
∙ Rigor, hard work, and excellence
Mission
Luxempart ambitions to embark on
enthousiastic growth journeys alongside
passionate entrepreneurs and best-in-
class fund managers, bringing great
companies to the next level of their
development.
Focus
We invest in proven companies with
strong market positions, a robust cash
flow generation, and significant growth
potential.
We accompany our partners through
active ownership, helping them achieving
superior growth, organically or through
a buy-and-build strategy.
Our unique presence in France and in
Germany enables to set bridges between
those two large markets, and even further.
Our
Foundations Statement
With a family and entrepreneurial
history dating back more than 30 years,
Luxempart has strongly anchored in its
gene the commitment of value creation
through long-term partnership.
10ꢀ -ꢀ LUXEMPART ANNUAL REPORT 2025
Not named
ONE STRATEGY
LOWER MID-CAP BUYOUT INVESTOR
ACROSS TWO ACTIVITIES
Direct Investments
2/3
1/3
Ticket in private and listed equity
€ 25-100m
Investment Funds
Target commitment
€ 10-25m
GEOGRAPHICAL FOCUS
Mainly in DACH, Belux, France and Italy
GEOGRAPHICAL DIVERSIFICATION
Europe and US
LOCAL CHAMPIONS
Investment in cash-generating companies
with strong market position
INVESTMENT FOCUS
Small to mid-sized buyout, buyout growth,
secondaries, and co-investments
ACTIVE INVESTOR
Minority or majority stake, flexible
investment horizon
PASSIVE INVESTOR
Exposure through leading fund managers
PREFERRED SECTORS
Software, healthcare, industrials, B2B services, financial services
LUXEMPART ANNUAL REPORT 2025ꢀ -ꢀ 11
Not named
12ꢀ -ꢀ LUXEMPART ANNUAL REPORT 2025
Not named
LUXEMPART ANNUAL REPORT 2025ꢀ -ꢀ 13
Not named
2,526m
+11.3%
NAV AT 31/12/2025
€ 2.56
-10.6%
DIVIDEND PER SHARE PROPOSED TO THE AGM
€ 212m
LIQUIDITIES AVAILABLE TO INVEST
GLOBAL PERFORMANCE IN 2025
SHARE PRICE PERFORMANCE IN 2025 (EXCL. DIVIDEND)
€ 225m
UNDRAWN CREDIT FACILITIES
FOCUS ON OUR
ACTIVITIES
14
-
LUXEMPART ANNUAL REPORT 2025
FOCUS ON OUR ACTIVITIES
Not named
NAV evolution (in EUR m)
NAV 31/12/2024
2,310.7
Performance
Dividend paid
-46.9
-12.3
+274.1
Operating & financial
result
NAV 31/12/2025
OPEX <1%NAV
2,525.6
Net Asset Value increased by 9.3% during the year, reflecting strong portfolio performance (+11.9%), our dividend paid out
(-2.0%), and our operating & financial result (-0.6%).
Net Asset Value allocation (in EUR m)
31/12/2024
31/12/2025
1,662.5
639.1
Direct Investments ꢀ
Investment Funds ꢀ
Cash & Other
1,530.9
191.9
9.3%
2,310.7
224.0
2,525.6
588.0
As at 31 December 2025, Direct Investments remain the largest component of the portfolio (66% of NAV). Investment
Funds continue to provide diversification across sectors and geographies. The higher cash balance at year-end reflects
recent realisations and provides flexibility to pursue new investment opportunities.
LUXEMPART ANNUAL REPORT 2025
-
15
Not named
Share Price and NAV evolution (in EUR)
1992
1995
1998
2001
2007
2010
2013
2016
2019
2022
2025
Share price ꢀ
NAV per share
140
105
70
35
0
Share price IRR (33 years) 15.2% p.a.
-49.7%
While Luxempart's NAV per share has shown strong growth over the long term, the share price declined during 2025,
resulting in a significant discount to NAV at year-end. Management considers this level of discount very high given
the quality of our portfolio and the Group's strong balance sheet.
Long-term performance vs benchmark (%p.a.)
25%
22.8%
20%
15%
10%
8.5%
5%
0%
1 year
11.3%
3 year
15.2%
6.9%
7.4%
5 year
10.1%
10.7%
10 year
4 year
5.5%
5.7%
MSCI Europe Mid Cap Net Return EUR index
LUXEMPART NAV
Luxempart's return is presented on a total return basis, with dividends included.
While the one and three-year performance is below the benchmark, Luxempart's NAV continues to outperform the
MSCI Europe Mid Cap index over the longer term.
16ꢀ -ꢀ LUXEMPART ANNUAL REPORT 2025
Not named
Gross Dividend per share (in EUR)
Dividend per share
3
2.25
1.5
0.75
0
Dividend Yield 2026: 4.1%
1992
1995
1998
2001
2007
2010
2013
2016
2019
2022
2025
Gross dividend per share-recent years (in EUR)
CAGR (20222026): 9.2%
2.56
2022
2023
2024
2025
2026 (Proposed)
3.00
2.50
2.33
2.00
1.98
1.50
1,00
0.50
0.00
2.17
1.80
In line with its policy of targeting annual dividend growth of 8–10%, the Group has continued to increase its dividend
per share. The proposed dividend reflects the Group's consistent value creation and disciplined capital allocation.
LUXEMPART ANNUAL REPORT 2025ꢀ -ꢀ 17
Not named
DIRECT
INVESTMENTS
€ 1,663m
+14.3%
NAV
2+7
3
NEW AND ADD-ONS INVESTMENTS
€ 92m
INVESTED
27
ACTIVE PORTFOLIO LINES
PERFORMANCE
EXITS
€ 141m
PROCEEDS RECEIVED
18
-
LUXEMPART ANNUAL REPORT 2025
FOCUS ON OUR ACTIVITIES
Not named
Positive development of our
Private Equity portfolio (+12.9%
performance), partially driven by
the strong contribution of Foyer
Group in a favourable environment
for insurance companies
Strong performance of our Listed
portfolio (+21.7%), supported
by solid underlying dynamics at
Tonies, Medios and Technotrans
Reinforcements in selected listed
positions in 2025: Atenor, Medios,
Tonies
Strengthening of the French
and German investment teams
April
NEXUS
Divestment and co-investment in Nexus AG,
and delisting of the company end of 2025
May
ENGINEERING SERVICES PLATFORM
Launch of a buy-and-build platform in the
engineering services sector in Germany
June
MARLINK
Exit of our remaining stake in Marlink,
generating a total MoM of 2.4x and an IRR
of 18.6%
IHS TOWERS
Exit of non-strategic position in IHS Towers,
as part of our portfolio streamlining
July
November
ASSMANN
Reinforcement of our participation in
Assmann GmbH and acquisition of a
controlling stake
VALEARA
Signing of a new controlling investment
in German outpatient healthcare provider
Valeara. Closing completed in January 2026
INVESTMENT ACTIVITY HIGHLIGHTS
LUXEMPART ANNUAL REPORT 2025
-
19
Not named
DIVESTMENT ACTIVITY
Luxempart exits its Direct Investments once the invest-
ment thesis has been delivered and the company is ready
for its next phase of development. Our divestments
demonstrate our ability to build value over time and
to crystallize it in a disciplined manner, while actively
rotating capital towards new opportunities.
3 EXITS IN 2025
Takeover by TA Associates
Gross proceeds of EUR 123m
1.4x MoM
In April 2025, Luxempart completed
the disposal of its stake in Nexus
following the successful public take-
over bid by TA Associates and the
subsequent delisting of the company.
Since 2022, Luxempart had been
an anchor shareholder of Nexus,
accompanying the company during
a period of strategic acceleration and
European expansion in healthcare
software. The successful execution of
the investment thesis led to a timely
realization.
Exit of the remaining stake
EUR 53.7m total proceeds
2.4x MoM | 18.6% IRR
In 2025, Luxempart exited its
remaining stake in Marlink, com-
pleting a long-term investment cycle
in the satellite connectivity sector.
Over the holding period, Marlink
strengthened its international
footprint and consolidated its posi-
tioning in a structurally growing
market, enabling Luxempart to
realize value successfully.
Exit of the remaining stake
EUR 4.9m proceeds in 2025
In June and July 2025, Luxempart
exited its non-strategic position in
IHS Towers, a telecom infrastructure
company. The divestment followed a
positive share price performance in
the first half of the year and gene-
rated EUR 4.9m in cash proceeds,
allowing the reallocation of capital
to higher-conviction investments.
20
-
LUXEMPART ANNUAL REPORT 2025
FOCUS ON OUR ACTIVITIES
Not named
INVESTMENT ACTIVITY
Luxempart invests with a long-term horizon, partnering
with entrepreneurial management teams and supporting
companies throughout their development and trans-
formation phases. Our investment strategy focuses on
acquiring meaningful positions in resilient businesses
with strong market positioning and scalable business
models. In 2025, the Group continued to deploy capital
actively across new majority investments and selected
portfolio reinforcements.
INVESTMENTS HIGHLIGHTS IN 2025
- Reinvestment alongside new ownership
- Healthcare software in Germany
Following the public takeover of Nexus by TA
Associates, Luxempart reinvested alongside the
new majority shareholder, reaffirming its confidence
in the company's long-term growth prospects. The
reinvestment underlines Luxempart's conviction in
Nexus' strong positioning in the European health-
care software market and its capacity to generate
sustainable value over time.
ENGINEERING SERVICES
PLATFORM
- New majority investment
- Industrial engineering services
In 2025, Luxempart established a new engineering
services platform. Operating in a technically demanding
industrial environment with attractive consolidation
potential, the platform follows a buy-and-build strategy
aimed at creating a leading regional player. As at 31
December 2025, two acquisitions had already been
completed, marking the first phase of its development.
This initiative reflects Luxempart's continued commit-
ment to building scalable platforms with long-term
value creation potential.
- Increase to strategic majority stake
- IT infrastructure & workplace solutions
- DACH-based | Pan-European growth
In 2025, Luxempart increased its stake in Assmann
Group to a majority position, reinforcing its long-
term commitment to the company's development.
Having partnered with the Assmann family since
2019, Luxempart now assumes the role of the lead
shareholder, with the family remaining invested. The
transaction reflects the strong collaboration established
over the years and supports the company's next phase
of organic and external growth.
- New majority investment
- Closing in January 2026
- Healthcare services in Germany
In 2025, Luxempart entered into an agreement to
become the majority shareholder of Valeara, a leading
provider of outpatient mental healthcare services in
Germany. The transaction was closed in January 2026.
Valeara operates an integrated platform addressing the
structural undersupply of mental healthcare services.
This investment further strengthens Luxempart's
exposure to healthcare and reflects its conviction
in long-term structural growth drivers.
LUXEMPART ANNUAL REPORT 2025
-
21
Not named
Strong market position
∙ Undisputed insurance market leader in
Luxembourg
∙ Strong position within its international niche
markets
Operating in growing markets
∙ Growth in both core Luxembourg market (average
EU GDP and population growth) and through
exposure to niche markets with ample white space
With a successful diversification in
wealth management
Capital@Work is among the last independent
asset managers in the Benelux
∙ Strong AUM basis over EUR 11bn, steadily grow-
ing (CAGR of c. 6% over the last 5 years)
Strong capitalization
∙ Solvency ratio of 285% (FY25E), largely above
peers (215% on average)
∙ No leverage
Robust and recurring performance
∙ Strong and growing net income, reflecting the
group's positioning in profitable markets, with a
good mix of insurance and investment results
∙ Significant and growing dividend payments
ensuring recurring revenues to Luxempart
INVESTMENT HIGHLIGHTS
FOCUS ON FOYER GROUP
Foyer Group has been the historical asset of the
Luxempart reference shareholders, with a history dating
back more than 100 years. Luxempart holds a 32% stake
into Foyer Group, next to the founding families.
Foyer Group has developed into the leading insurance
company in Luxembourg, providing a full coverage of
insurance products (life and non-life) via its strong net-
work of exclusive agents.
It has over time diversified internationally into niche
insurance markets (e.g. health insurance for expatriates,
cross-border life insurance) as well as into wealth man-
agement, through Capital@Work.
Foyer Group today accounts among the key players
within the Luxembourg financial services landscape,
and benefits from a strong visibility and reputation on
the market.
22
-
LUXEMPART ANNUAL REPORT 2025
FOCUS ON OUR ACTIVITIES
Not named
STRONG TRACK RECORD OF FINANCIAL PERFORMANCE
Net income1 - (in EURm)
2018 2019 2020 2021 2022 2023 2024 2025E
94
103
98
156
147
151
151
185
1.4
Shareholders equity1 - (in EURbn)
2018 2019 2020 2021 2022 2023 2024 2025E
1.1
1.3
1.3
1.2
1.3
1.3
1.6
ATTRACTIVE SHAREHOLDER RETURNS WHILE MAINTAINING STRONG CAPITALIZATION
Foyer
285%
Peer group
215%
Solvency II ratio vs. peer group
Foyer Group FY25E, peer group latest available
Shareholder returns (incl. dividends)
c.15%
IRR SINCE 2018
60%
TARGET DIVIDENT PAYOUT RATIO
1) In Lux GAAP FVO - Fair value option, group share
LUXEMPART ANNUAL REPORT 2025
-
23
Not named
FOCUS: LISTED DACH INVESTMENTS
A PRIVATE EQUITY MINDSET APPLIED
TO PUBLIC MARKETS
Luxempart pursues an entrepreneurial, long-term ori-
ented direct investment strategy and applies this also
to listed small- and mid-cap companies in the DACH
region. This segment offers an attractive and often
underappreciated opportunity set, driven by declining
analyst coverage, limited institutional ownership and
persistent valuation discounts relative to large-cap
equities, despite robust fundamentals and compelling
growth prospects.
Our track record as an active anchor shareholder is
evidenced by successful long-term engagements in com-
panies such as Schaltbau AG, Nexus AG, and zooplus
AG – all of which were ultimately acquired by private
equity investors and taken private.
Our strategy bridges the advantages of public market liquidity with private equity-style value creation along three
core pillars:
Significant minority stakes
We typically acquire cornerstone positions
that grant us a meaningful voice and a 'seat
at the table'.
Long-term horizon
We focus on sustainable value creation, deliberately prioritizing long-term outcomes over short-term market volatility.
Active governance
We actively seek Supervisory Board representation to
support management teams in M&A execution, strategic
repositioning, and operational efficiency programs.
MSCI Europe Small Cap vs. Large Cap Premium (+) / Discount () based on EV/EBITDA NTM
80%
60%
40%
20%
0%
-20%
-40%
-60%
Jan
2015
Jan
2016
Jan
2017
Jan
2018
Jan
2019
Jan
2020
Jan
2021
Jan
2022
Jan
2023
Jan
2025
Jan
2024
Dec
2025
Source: Bloomberg data January 29, 2010 – December 31, 2025 (monthly) for MSCI EMU Small Cap Net Return EUR Index (M7EMSC) and MSCI EMU
Large Cap Net Return EUR Index (M7EMLC)
24
-
LUXEMPART ANNUAL REPORT 2025
FOCUS ON OUR ACTIVITIES
Not named
Technotrans delivered materially improved
profitability in 2025. This operational turnaround
translated into a share price increase of +84% in
2025, underlining renewed market confidence
in the company's strategy, execution capabilities
and leadership team.
Besides its historical markets, Technotrans is well
positioned to benefit from the strong demand
for data centers, arising from the artificial intel-
ligence boom.
During 2025, tonies made important strategic
progress, most notably with the successful launch
of the second-generation Toniebox, further
strengthening the platform's product offering
and user experience. At the same time, the com-
pany continued to execute on its international
growth strategy, with strong momentum in the
United States, driven by increasing household
penetration and expanding brand awareness.
These developments, combined with improving
operating leverage, contributed to a share price
increase of +43% in 2025.
Nexus was successfully removed from the public
listing in December 2025, following to the take-over
bid realized by TA Associates on the company in
April 2025. This operation shows the attractiveness
and relatively low valuations of small and mid
cap listed companies in the current environment.
In 2025, Medios delivered solid operational
performance, which, together with increasing
investor confidence and positive expectations
surrounding the new management team, resulted
in a share price increase of +10% over the year.
With strengthened governance, a clear strategic
direction and attractive underlying market
dynamics, Medios is well positioned to continue
generating sustainable shareholder value.
LUXEMPART ANNUAL REPORT 2025
-
25
Not named
INVESTMENT
FUNDS
€ 639m
+9.9%
NAV
€ 949m
65
TOTAL EXPOSURE
€ 138m
9
NEW COMMITMENTS
€ 74m
CAPITAL CALLED
PERFORMANCE
FUNDS
NEW MANAGER RELATIONSHIPS
€ 81m
PROCEEDS RECEIVED
26
-
LUXEMPART ANNUAL REPORT 2025
FOCUS ON OUR ACTIVITIES
Not named
ACTIVITY HIGHLIGHTS
NAV by Strategy
BUYOUT
70.8%
GROWTH
EQUITY
10.4%
SECONDARIES
8.3%
VENTURE
VENTURE
CAPITAL
10.5%
CAPITAL
€ 639m
NAV b
y Geogr
EUROPE
65.4%
ASIA
2.6%
16.2%
15.8%
€ 639m
Undrawn Commitments by Strategy
BUYOUT
64.3%
GROWTH
EQUITY
18.8%
SECONDARIES 13.4%
3.6%
€ 310m
aph
y
Undrawn Commitments by Geography
EUROPE
34.9%
ASIA
2.6%
NORTH
NORTH
AMERICA
AMERICA
51.1%
ROW
ROW
11.4%
€ 310m
2025 COMMITMENTS
The new commitments reflect the Group's continued focus on technology and software, in line with its long-term investment priorities, while also
addressing areas of relative under-exposure within the portfolio.
Commitments by Geography
Commitments by Strategy
BUYOUT
70.0%
EUROPE
33%
GROWTH
EQUITY
20.1%
SECONDARY
FUNDS
9.9%
NORTH
AMERICA
67%
138m
LUXEMPART ANNUAL REPORT 2025
-
27
Not named
NEW COMMITMENTS & MANAGERS
During the year, we have committed EUR 137.6m across eleven Fund Managers, three in Europe and eight in the US:
Banneker Partners
Software
Operationally-oriented, software-focused lower middle-
market investor — Banneker Partners specializes in part-
nering with founders and management teams in the lower
middle market to invest in and grow software companies,
bringing deep operational insight and hands-on support
to accelerate performance.
Bravo Capital Partners
Generalist
Italian SME private equity specialist — Bravo Capital
Partners focuses on acquiring and developing small and
medium-sized Italian companies with strong growth
prospects, often backing building platforms and buy-and-
build strategies in domestic sectors.
BV Investment Partners
IT & Tech-enabled B2B services
Tech-enabled business services & IT investor — Boston-
based BV Investment Partners targets middle-market
opportunities in technology-enabled business services,
software, communications and IT services, combining
strategic investment with operational enhancement.
JMI Equity
Software
Growth equity for software & AI-driven companies — JMI
Equity is dedicated to investing in high-growth software
and AI-enabled businesses with proven models and
recurring revenue, deploying capital and strategic support
to scale operations and maximize long-term value.
K1 Investment Management
Software
High-growth enterprise software buyout partner — K1
is a software buyout specialist that works closely with
management teams of high-growth B2B enterprise soft-
ware companies, applying operational expertise and
AI-led growth strategies to build category leaders.
Marlin Equity Partners
Software
Complex situations across B2B software and tech ser-
vices — Marlin Equity Partners is a US-based private
equity investor known for focusing on special situations
and transformational opportunities across B2B software
and technology sectors, often involving restructuring or
turnarounds.
28
-
LUXEMPART ANNUAL REPORT 2025
FOCUS ON OUR ACTIVITIES
Not named
Monterro
Nordics B2B software buyout investor — Monterro
focuses exclusively on buyout investments in B2B soft-
ware companies out of the Nordic countries, backing plat-
forms with strong market positions and growth potential.
RCP Advisors
Generalist
Emerging small-cap private equity platform investor
— RCP Advisors is a private equity platform that concen-
trates on identifying and supporting emerging small-cap
fund managers and investment teams in growing their
capabilities and portfolio exposure.
Silversmith
Technology, Software and Healthcare IT
Growth equity in SaaS, information services & healthcare
IT — Silversmith specializes in growth equity investing
focused on SaaS, information services and healthcare IT
and services businesses, backing companies with scalable
technology and strong growth trajectories.
STG Partners
Software
Software
Software & software-enabled technology services
builder in the US and Europe — STG is a private equity
firm that builds and grows mid-market software and
software-enabled services companies, often through
strategic acquisitions and operational support.
Windrose Health Investors
Healthcare
Healthcare quality & efficiency-focused investor
Windrose Health Investors targets businesses that improve
quality and enhance efficiency in the healthcare ecosys-
tem, backing innovative companies that address systemic
challenges and drive measurable care improvements.
LUXEMPART ANNUAL REPORT 2025
-
29
Not named
PORTFOLIO CONSTRUCTION
Annual Commitments by Strategy (in EUR m)
160
140
120
100
80
60
40
2
20
2
0
2016
2017
5
Buyout
Growth Equity
Secondary Funds
Venture Capital - Number of new funds/year
2018
2019
2
12
2020
3
2021
10
2022
2023
10
2024
6
2025
12
Commitments remain predominantly oriented toward buyout strategies, complemented by selective allocations to
growth and secondary funds. Venture exposure reflects legacy positions.
Total exposure by geography (in EUR m)
Europe
North America
ROW
Asia
Total number of funds
1 000
65
900
53
800
47
700
25
600
500
25
400
22
300
13
200
100
0
2016
2017
18
20
2018
2019
2020
2021
2022
37
2023
2024
2025
The portfolio retains a strong European foundation while increasing North American exposure in line with its long-term
geographic diversification strategy. Rest of world comprises funds that act globally, including in the US and Europe.
30
-
LUXEMPART ANNUAL REPORT 2025
FOCUS ON OUR ACTIVITIES
Not named
LONG-TERM PERFORMANCE AND CASH CURVE
Net IRR vs benchmark
Luxempart Investment Funds
Cambridge Associates benchmark
20%
15%
13.7%
10%
5%
4.2%
0%
1Y
9.9%
3Y
10.6%
2.2%
5Y
17.7%
The performance over one-, three-, and five-year periods is measured using the internal rate of return (IRR), calculated
on the basis of cash flows, including capital calls and distributions, as well as the valuation of the portfolio at the
relevant reporting dates. Reported performance includes the impact of foreign exchange movements.
Source: Benchmark data are based on Cambridge Associates and presented net of fees. Returns are shown in EUR as of Q3 2025 and cover buyout,
growth, secondary, and venture capital funds in North America and Europe. Luxempart Q3 2025 NAV weighting per strategy has been applied to derive
the benchmark figures. Vintage year refers to the year of first investment. Data are subject to revision. © 2026 Cambridge Associates. All rights reserved.
Cumulative Capital Invested and Distributed (2021–2025) (in EUR m)
Cumulative paid-in
Cumulative distributions
Cumulative net
400
386
300
200
100
0
3
-100
-200
-300
-400
-383
2021
2022
2023
2024
2025
Over the past 5 years, the program has been self-funded while generating slightly above EUR 350m of value creation.
LUXEMPART ANNUAL REPORT 2025
-
31
Not named
32ꢀ -ꢀ LUXEMPART ANNUAL REPORT 2025
Not named
LUXEMPART ANNUAL REPORT 2025ꢀ -ꢀ 33
Not named
ACTIVITY &
PERFORMANCE
MANAGEMENT REPORT
GLOBAL CONTEXT
2025 has proven to be a highly unpredictable year on
many fronts. International trade came under pressure
from new tariffs, while long-standing strategic alliances
were increasingly reassessed. Relationships that had
been built over decades were, at times, tested by short-
term negotiation dynamics. At the same time, efforts to
advance peace talks in the Russia-Ukraine conflict delivered
limited progress. Although geopolitical developments
generated elevated policy uncertainty and market volatility,
concrete outcomes remained constrained, contributing
to a more complex investment environment In such an
environment, wise investors sought to remain disci-
plined, focusing on long-term fundamentals to guide
their investment decisions.
Overall, both the American and European economies
proved relatively resilient, with GDP growth ranging
between 1.5% and 2.0%. Growth was driven by contained
inflation and gradually declining interest rates, follow-
ing policy easing by both the Federal Reserve and the
European Central Bank.
Equity markets, despite heightened volatility, delivered
solid overall returns in 2025. In the United States, per-
formance was largely driven by continued strength in
the technology sector, while European markets regained
momentum on the back of large-scale government
spending programs.
The US dollar, however, weakened materially over the
year amid growing concerns over the country's growing
indebtedness. It depreciated by 13% against the euro,
reaching 1.17 USD/EUR, negatively impacting returns on
US-denominated assets for European-based investors.
LUXEMPART PERFORMANCE
Luxempart achieved a strong second half-year 2025
with an overall performance of +8.6% over the period.
Both Direct Investments and Investment funds con-
tributed positively with returns of +10.4% and +7.3%
respectively.
On the whole year, our NAV increased by +9.3%, crossing
for the first time the EUR 2.5bn bar, at EUR 2,526m, com-
pared to EUR 2,311m at 31 December 2024. Adjusted
for the dividend paid in May 2025, the overall Group's
performance was of +11.3% in 2025; and adjusted for
negative currency effects over the year, our annual per-
formance would have been of +11.9%.
Over a 4-year period, Luxempart has generated an annu-
alised IRR of 5.7%, below our long-term track record. This
can be explained by the difficult environment private
equity has been navigating through since 2022, when
interest rates increased and transaction levels slowed
down. This return still compares favorably to our bench-
mark index, the MSCI Europe Mid Cap Net return index
which generated an annualised IRR of 5.45% over the
same period.
2025 was marked by one large exit of Nexus AG in
April and two smaller disposals (the completion of our
investment in Marlink and the sale of our non-strategic
listed holding in IHS). On the front of new investments,
the acquisition of German mental healthcare platform
Valeara was signed in November 2025, and 12 new
commitments were taken in Investment Funds, primarily
in the US. In total we deployed EUR 165.3m in 2025,
across both activities, while generating EUR 255.5m of
proceeds, fund distributions and income from portfolio
companies (including dividends).
Our Group's financial liquidity stood at EUR 212.1m, or
8.4% of our total NAV, providing flexibility to pursue
attractive opportunities on the market. This liquidity
position is complemented by five committed credit
facilities of EUR 225.0m in total. Those credit facilities
were totally undrawn at 31 December 2025.
Aligned with our long-term investment philosophy, in
2025 we became a signatory to the United Nations-
supported Principles for Responsible Investment (PRI).
34
-
LUXEMPART ANNUAL REPORT 2025
Not named
MAIN FINANCIAL INDICATORS (IFRS)
The financial statements of Luxempart have been pre-
pared in compliance with the International Financial
Reporting Standards for the year ending 31 December
2025.
Main KPI (in EUR m)
2025
2024 Variation
Equity (group share)
2,525.6
2,310.7
+9.3%
Net result
260.9
30.5
>100%
The Group equity of Luxempart strongly increased to
EUR 2,525.6m at 31 December 2025, primarily reflecting
the positive performance of our portfolio (EUR +276.6m),
partially offset by our operational expenses, staff cost
and taxes for the year (EUR -17.7m), and the dividend
paid out to our shareholders (EUR -46.9m).
In the statutory accounts of Luxempart (established
under Lux GAAP) the equity increased from EUR
1,210.1m as at 31 December 2024 to EUR 1,230.0m
as at 31 December 2025 and the net result increased
over the same period from EUR 24.2m to EUR 66.9m.
DIVIDEND
The Annual General Meeting of the shareholders held on
28 April 2025 approved the payment of a gross divi-
dend of EUR 2.33 per share. This dividend represented
a total amount of EUR 46.9m for Luxempart in 2025,
which was paid on 15 May 2025. Based on a Luxempart
share price of EUR 70.50 per share as at 31 December
2024, this represented a gross dividend yield of 3.3%
for our shareholders.
The Board of Directors will propose to the Annual General
Meeting on 27 April 2026 to approve the payment of a
gross dividend of EUR 2.56 per share. This represents an
increase of 9.9% compared to prior year. Over a 4-year
period, the annual dividend growth rate stands at 9.2%.
Assuming the approval of this proposal, the dividend
will be payable from 15 May 2026.
OWN SHARES
As at 31 December 2025, Luxempart holds a total of
543,682 own shares which corresponds to 2.6% of the
issued share capital for a book value of EUR 24.0m.
During the year, Luxempart sold 15,500 own shares
for EUR 0.8m, in the context of stock options exercised.
These shares represent 0.1% of the share capital.
The Annual General Meeting of the shareholders held on
28 April 2025 has authorized to buy back up to 30% of
own shares for a price up to EUR 150 per share, for a
5-year term. This authorization will expire at the Annual
General Meeting to be held in 2030.
LUXEMPART ANNUAL REPORT 2025
-
35
Not named
SHARE PERFORMANCE
Luxempart shares are traded on the Luxembourg Stock
Exchange. In order to improve liquidity, KBC intervenes
as a liquidity provider on an independent but remune-
rated basis. It buys and sells on the market in line with
the market movements.
Luxempart share price ended the year 2025 at EUR 63.0
decreasing by -10.6% compared to 31 December 2024,
running counter to the Group's underlying performance.
This share price represents a record high 49.7% discount
to our end-of-year NAV, which management judges
excessive, given the Group's financial liquidity of EUR
212.1m, its 32% stake in highly capitalised and resilient
Foyer Group, and its diversified portfolio.
RECENT POST CLOSING
EVENTS
On 29 January 2026, Luxempart closed a majority
investment (>75%) into Valeara, a German healthcare
provider. Valeara is the only multi-regional outpatient
mental healthcare platform in Germany with over 700
employees serving more than 220,000 patient cases
per annum. The company provides outpatient-focused
services in psychology, psychiatry, and neurology
through an integrated platform of different care settings
and interdisciplinary teams. Genui, the former owner of
Valeara, together with the management team, remained
invested in the company alongside Luxempart.
OUTLOOK
It is difficult to make forecasts for the coming years in
a context marked by persistent geopolitical tensions
and major technological advances, particularly in the
field of AI.
Looking back, it is clear that recent years have been
characterized by a series of shocks and uncertainties —
COVID, the war in Ukraine, trade tariffs, among others.
And yet, the global economy has repeatedly demon-
strated a remarkable capacity to adapt. This encourages
us, with our long-term perspective, to focus on structural
trends beyond temporary disruptions.
In this volatile environment, the key to success is to
invest in strong companies that address clear market
needs, and to acquire them at reasonable valuations,
while maintaining good diversification.
In this respect, our portfolio showed a positive trend
during the second half of 2025, and we are confident
that it can continue on this trajectory in 2026. Foyer
Group remains very well oriented, with a strong posi-
tioning in its core markets. As for our investment fund
program, it is beginning to reach greater maturity, which
should translate into continued strong performance in
the future. Finally, our significant liquidity position ena-
bles us to consider new acquisitions in 2026, depending
on the opportunities that will arise.
True to its principles, Luxempart continues to patiently
build solid foundations for a robust future. We remain
focused on achieving annual returns above 12% and are
fully committed to reaching this objective.
36
-
LUXEMPART ANNUAL REPORT 2025
MANAGEMENT REPORT
Not named
LUXEMPART ANNUAL REPORT 2025
-
37
Not named
PERFORMANCE
The yearly performance of our Direct Investments
portfolio has been solid in 2025, at +14.3%, composed
of EUR 180.9m of valuation increase and EUR 34.0m
dividends received.
The second half of the year was especially strong, our
portfolio showing a +10.4% increase in value over the
semester. This increase was visible in all our segments
of activities.
Foyer Group showed another strong year-half, both
in its insurance and investment results, leading to a
record year for this company. Its valuation was also
positively impacted by increases in multiples on both
Price to Earnings (P/E) and Price to Book (P/book) ratios
in the European Insurance sector, the sector being well
oriented on the stock markets in 2025.
Our Private equity portfolio also progressed in 2025,
driven by strong operational performances in some of
our larger portfolio companies like Evariste, Alphacaps
or Nexus, and despite the fact that both the economic
fundamentals and transaction environment remained
subdued in Europe. Our portfolio, being mostly local,
has not been impacted too much by the trade tariffs
launched by the US as from March 2025. The general
context and the unpredictability of some measures
however weigh on consumer and investor's confidence,
resulting in reduced levels of investments in many sectors.
Finally, our Listed portfolio performed very well during
the second half of the year, based on strong underlying
operational results at Medios, Tonies and Technotrans,
that were finally reflected in their share prices. On the
full year 2025, our listed portfolio increased by 21.7%,
despite a weak performance of Atenor, that continued
to suffer from adverse market conditions in the con-
struction sector.
Our actual portfolio remains very sound. Our compa-
nies' weighted average EBITDA progressed by 10.4%,
showing good operational performance. Our portfolio
(excl. Atenor) leverage ratio stands at a reasonable 3.0x
EBITDA (from 2.9x EBITDA in pro forma 2024), and our
weighted average valuation multiples stand at 10.6x
EBITDA (vs. 10.7x EBITDA in pro forma 2024).
Our portfolio is composed of 27 companies well diver-
sified across Benelux, Germany, France and Italy, with
exposures to less cyclical sectors such as healthcare,
business services, and financial services, offsetting our
more volatile cyclical industrial holdings. Furthermore,
the portfolio is largely composed of local champions,
which are less exposed to currency volatility or trade
policy uncertainty.
Movement in Direct Investments NAV (in EUR m)
NAV DI 31/12/2024
1,530.9
Valuation effect
Investments
+91.7
+180.9
1,662.5
Exits
-140.9
NAV DI 31/12/2025
DIRECT
INVESTMENTS
38
-
LUXEMPART ANNUAL REPORT 2025
MANAGEMENT REPORT
Not named
In April 2025, the already announced take-over bid of
Nexus AG by TA Associates was finalized, generating
gross proceeds of EUR 123m for Luxempart, and a 1.4x
multiple on money invested (MoM).
We exited our remaining stake in the French satellite
company Marlink, realizing EUR 11.7m in proceeds. In
total this investment generated EUR 53.7m, representing
a 2.4x MoM and an IRR of 18.6%.
Finally, we decided to exit from our non strategic posi-
tion in listed telecom company IHS, on the back of a
positive share price increase of this company over the
first half of the year. This sale, realized between June
and July 2025, generated a cash proceed of EUR 4.9m
for Luxempart.
We had an active year in terms of sourcing and new
project build ups in 2025, although some were closed
only early 2026.
In April 2025, we made a EUR 48m co-investment
in Nexus AG, alongside partner TA Associates, as we
decided to keep some exposure on this company in its
take-private journey. Nexus is a company situated at
the crossroads between software and healthcare, two
sectors we like a lot. We believe there is still a lot of
value to be created in this space in the coming years.
And TA Associates is a reputable investor, expert of
software investing we are happy to partner with in this
new chapter of Nexus development.
Mid-2025 we launched a new buy-and-build platform
with partners in Germany, in the business engineering
space. Two first companies were purchased in 2025,
establishing the nucleus for this new buy-and-build
platform.
In November 2025 we announced the signing of an
agreement for the acquisition of a majority stake in
Valeara, the largest multi-regional outpatient mental
health platform in Germany. This deal was successfully
closed on 29 January 2026.
Finally we decided to reinforce our positions in a few
portfolio companies, over the course of 2025: Assmann,
Atenor, Tonies and Medios.
Divestment Investment
activity
activity
LUXEMPART ANNUAL REPORT 2025
-
39
Not named
Our Investment Funds activity performed well in 2025,
generating a 9.9% return for Luxempart.
On an adjusted basis for currency effects, our perfor-
mance would have been higher, at 12.2%, reflecting
the -13.0% depreciation of the USD during the year,
which had a negative impact of EUR -13.2m on our
performance.
This performance was primarily driven by our core
buy-out strategy, which generated a +13.7% return over
the year, supported by a few significant exits within
our mature sponsor-backed funds at valuations largely
exceeding their latest NAVs.
Mature sponsor relationships remain key contributors to
portfolio performance. Our growth equity and seconda-
ries strategies delivered respecively a slightly positive
return, at 4.2% and 2.8%, while venture capital exposures
was negative (-2.7%). Venture exposure relates to legacy
positions and is no longer a focus of new commitments.
In absolute terms, the Net Asset Value of our Investment
Funds increased from EUR 588.0m in 2024 to EUR 639.1m
at year-end 2025.
Over the past decade, Luxempart's investment funds pro-
gram has undergone a gradual evolution in its portfolio
construction, geographic allocation and strategic focus.
Until 2019, commitments were typically characterized
by larger ticket sizes concentrated in a limited number
of funds. While this approach provided meaningful
exposure to high-quality managers, it also resulted in
a higher concentration of NAV, notably within a small
number of large sponsor-backed platforms that remain
significant contributors to the portfolio today.
From 2021 onwards, Luxempart progressively refined its
deployment model. Commitments have been deployed
across a broader set of manager relationships, enhancing
diversification across managers, vintages and strategies.
Annual commitment levels have been managed within
a disciplined pacing framework, supporting portfolio
balance and capital visibility.
INVESTMENT
FUNDS
Movement in Investment Funds NAV (in EUR m)
NAV IF 31/12/2024
588.0
Contributions
+73.7
+58.0
Distributions
-80.6
Valuations effect
NAV IF 31/12/2025
639.1
Undrawn capital
+310.0
949.1
Total exposure
40
-
LUXEMPART ANNUAL REPORT 2025
MANAGEMENT REPORT
Not named
New
Commitments
In 2025, Luxempart committed EUR 137.6m to 12 new funds, of
which 8 were US managers.
Commitments during the year reflect Luxempart's focused investment
approach, maintaining a strong anchoring in Europe while increasing
exposure to the US.
This brings our exposure outside of Europe (US and Rest of World) to
EUR 420m, representing 42% of our total Investment funds' exposure,
compared to 32% at year-end 2024. While historical exposure to
software remained limited, and given the acceleration of Artificial
Intelligence and its potential significant impact on disrupting business
models, we considered it appropriate to selectively increase our
exposure to this vertical, where several of opportunities will arise
in the coming years. We therefore decided to concentrate a larger
share of our commitments on this particular vertical for our cohort
2024-2026, through carefully selected, often heavily oversubscribed
managers, in the US and Europe.
Our total undrawn commitments stand at EUR 310.0m end of 2025.
Undrawn levels are actively monitored to ensure alignment with
projected cash flows and commitment pacing.
Cash
Deployments
The Group deployed EUR 73.7m through
capital calls from its fund commitments in
2025, reflecting a slower deployment pace
across the private equity market compared
to prior years.
The portfolio generated EUR 80.6m in cash
proceeds during the same period, following
significant exits realized within several
mature funds. This represents a 13.8% yield
on our opening balance.
LUXEMPART ANNUAL REPORT 2025
-
41
Not named
SUSTAINABILITY
This sustainability statement presents the actions under-
taken over the past 12 months across Luxempart's own
operations and its investment activities.
Over the past several years, Luxempart has progres-
sively integrated sustainability considerations into its
investment and corporate practices. Sustainability is
embedded as a disciplined approach supporting long-
term value creation, effective risk management and the
protection of Luxempart's reputation as a listed invest-
ment company. In 2025, the focus was placed on consol-
idating and formalising existing practices, strengthening
governance and ensuring consistency across the organi–
sation and throughout the investment lifecycle, rather
than introducing new commitments or targets.
This statement reflects Luxempart's pragmatic approach
to sustainability, aligned with its business model, invest-
ment philosophy and long-term orientation.
Key milestones in 2025
2025 marked an important step in strengthening
Luxempart's responsible investment approach, with two
key milestones achieved during the year:
• In March 2025, Luxempart became a signatory of the
United Nations-supported Principles for Responsible
Investment (PRI).
• In parallel, Luxempart approved a comprehensive
sustainability policy, formalising the principles and
practices already embedded across the investment
lifecycle.
These milestones aim to strengthen governance, con-
sistency and transparency, and to provide a recogni–
sed framework supporting disciplined investment
decision-making.
As a PRI signatory, Luxempart aligns with the six
Principles for Responsible Investment, which promote
the integration of environmental, social and governance
factors into investment analysis, ownership practices
and reporting. PRI participation is viewed as a recog-
nised framework to further structure and formalise
existing practices, rather than as a change in Luxempart's
investment philosophy. In this first year of participation,
the focus was placed on internal alignment, training and
the mobilisation of resources across teams, in line with
Luxempart's role as a long-term investor.
42
-
LUXEMPART ANNUAL REPORT 2025
MANAGEMENT REPORT
Not named
Sustainability embedded across the investment lifecycle
PRE-INVESTMENT
Governance, corporate
responsibility &
reputation risks
Materiality-driven and
proportionate approach
OWNERSHIP
& MONITORING
Priority topics: anti-
corruption, energy
efficiency, fair treatment
Practical tools (surveys,
whistleblowing)
REPORTING
& ENGAGEMENT
Streamlined ESG data
collection
Focus on decision-useful
information
In 2025, Luxempart further strengthened the way
sustainability considerations are embedded across the
investment lifecycle, with a focus on robustness, clarity
and relevance.
Sustainability is integrated primarily as a risk manage-
ment and value protection tool, supporting long-term
value creation. The PRI signature and the approval of the
sustainability policy during the year provided a clearer
framework to formalise practices already in place and to
ensure a consistent approach across teams and invest-
ment situations.
Pre-investment: refined risk & opportunity focus
During the pre-investment phase, sustainability-related
risks, opportunities and impacts (IRO) are assessed
alongside financial, operational and strategic considera-
tions. In 2025, particular attention was paid to IROs
linked to governance, corporate responsibility and reputa-
tion, reflecting their potential impact on downside risk
and long-term value protection.
Sustainability considerations are assessed in a pro-
portionate and materiality-driven manner, tailored to
the specific context of each opportunity. There is no
one-size-fits-all assessment, and materiality remains
a guiding principle, including when analysing exposure
to durable market trends, notably in sectors such as
healthcare.
Ownership and monitoring: clearer priorities
During the ownership phase, Luxempart engages with
portfolio companies on sustainability topics in a manner
consistent with its role as a long-term shareholder.
Building on feedback collected from portfolio compa-
nies, sustainability efforts in 2025 were deliberately
concentrated on a limited number of priority areas, in
order to support relevance, practicality and effective
implementation.
These priority areas included:
• governance and anti-corruption practices,
• energy efficiency where material,
• non-discrimination and fair treatment of employees.
This prioritisation aims to support meaningful actions
and constructive dialogue, allowing Luxempart and port-
folio companies to focus efforts where they matter most.
Reporting & engagement: deeper sustainability
integration
In parallel, Luxempart continued to streamline its ESG
data collection approach to ensure that information
requests remain proportionate and decision-useful.
Several portfolio companies continue to demonstrate
advanced sustainability practices, including the achieve-
ment of Gold and even one Platinum EcoVadis medals.
These examples illustrate how robust governance and
sustainability practices can contribute to operational
resilience, competitive positioning and reputational
protection, while remaining tailored to each business
context.
LUXEMPART ANNUAL REPORT 2025
-
43
Not named
SUSTAINABILITY AT CORPORATE LEVEL
At corporate level, Luxempart's sustainability approach
focuses primarily on people and business conduct. These
areas are considered essential to fostering organisa-
tional resilience, managing downside risks and preserving
stakeholder trust.
Pragmatic
Materiality-driven and proportionate
Disciplined
Embedded across the investment lifecycle
Focused
Priorities over broad data exercises
People, talent and culture
In 2025, Luxempart continued to focus on talent reten-
tion, development and employee engagement. Dedicated
training sessions on responsible investment were delivered
across the organisation, alongside a range of other training
initiatives, with a particular focus on governance and IT
security.
Employee engagement was also supported through initia-
tives such as participation in the Jonk Entrepreneuren
programme. Several employees contributed to training
students, and feedback from participants has been very
positive.
Luxempart continued to focus on attracting and recruiting
high-performing candidates at all levels, supporting
long-term organisational resilience and capability build-
ing. Significant work was carried out on the preparation
of a future remuneration framework, with the objective
of better reflecting employees' expectations and sup-
porting retention.
Governance, ethics and best
practices
Governance and business conduct remain key focus areas
for Luxempart. In 2025, work continued on reviewing,
updating and implementing governance frameworks and
internal procedures, with the objective of effective risk
management.
The approach aims to combine robust controls with
pragmatic implementation, ensuring effective risk
management while limiting unnecessary operational
burden. Governance practices are designed to support
regulatory compliance and to protect Luxempart's rep-
utation and the trust of its stakeholders.
Key areas addressed during the year included anti-
money laundering and counter-terrorist financing (AML/
CFT), the dealing code, data protection and informa-
tion security. Relevant policies and procedures were
reviewed and updated where appropriate, and aware-
ness and training activities continued to be delivered
to employees.
Environmental footprint
– first assessment
In 2025, Luxempart conducted its first greenhouse gas
(GHG) emissions footprint assessment at Group level.
This exercise aimed to gain a clearer understanding
of the main sources of emissions associated with the
Company's activities.
As for many private equity and investment firms, travel-
related emissions represent a significant share of the
footprint, reflecting the nature of Luxempart's invest-
ment activities and geographic footprint. While business
travel remains an integral part of Luxempart's work,
existing practices encourage lower-emission options
where they are operationally efficient, notably the use
of rail transport when appropriate.
This first assessment provides a baseline for future
monitoring and supports a more informed approach to
managing Luxempart's environmental footprint over
time.
44
-
LUXEMPART ANNUAL REPORT 2025
MANAGEMENT REPORT